Literature DB >> 15210668

Preterm meconium staining of the amniotic fluid: associated findings and risk of adverse clinical outcome.

A T Tybulewicz1, S K Clegg, G J Fonfé, B J Stenson.   

Abstract

BACKGROUND: The incidence of preterm meconium staining of the amniotic fluid (MSAF) is uncertain. It may be an indicator of possible listeriosis. It is unclear how great this risk is or whether preterm MSAF is a risk factor for adverse neonatal outcome.
OBJECTIVE: To investigate the incidence of preterm MSAF, the incidence of associated maternal and neonatal infection, and the outcomes of the infants at discharge.
DESIGN: Retrospective case-control study.
METHODS: Infants < 33 weeks gestation with preterm MSAF born in the Simpson Memorial Maternity Pavilion, Edinburgh between 1 January 1994 and 2 January 2001 were matched with the next infant of the same sex and gestation with clear liquor. Maternal and infant characteristics, culture results, placental histology, and clinical outcomes were compared.
RESULTS: Preterm MSAF was observed in 45/1054 (4.3%) infants below 33 weeks gestation. No maternal or infant listeriosis was identified in cases or controls. There was no significant difference in birth weight, Apgar score, or first pH between cases and controls. Preterm MSAF was associated with prolonged rupture of the membranes (odds ratio (OR) 3.34, 95% confidence interval (CI) 1.07 to 10.49), but not maternal hypertension, sepsis, or chorioamnionitis. Severe (grade 3/4) intraventricular haemorrhage was significantly more common in infants with preterm MSAF (OR 2.03, 95% CI 1.62 to 2.53). There was no significant difference in mortality. Early onset sepsis was observed in two cases and three controls.
CONCLUSIONS: Preterm meconium staining of the amniotic fluid may be associated with increased risk of intraventricular haemorrhage. It does not appear to be a useful indicator of listeriosis.

Entities:  

Mesh:

Year:  2004        PMID: 15210668      PMCID: PMC1721697          DOI: 10.1136/adc.2002.021949

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  6 in total

1.  Meconium-stained amniotic fluid and risk for cerebral palsy in preterm infants.

Authors:  A Spinillo; E Fazzi; E Capuzzo; M Stronati; G Piazzi; A Ferrari
Journal:  Obstet Gynecol       Date:  1997-10       Impact factor: 7.661

2.  Significance of meconium-stained amniotic fluid in the preterm population.

Authors:  H Scott; M Walker; A Gruslin
Journal:  J Perinatol       Date:  2001 Apr-May       Impact factor: 2.521

3.  Epidemic perinatal listeriosis.

Authors:  D Lennon; B Lewis; C Mantell; D Becroft; B Dove; K Farmer; S Tonkin; N Yeates; R Stamp; K Mickleson
Journal:  Pediatr Infect Dis       Date:  1984 Jan-Feb

4.  Meconium stained amniotic fluid in preterm delivery is an independent risk factor for perinatal complications.

Authors:  M Mazor; R Hershkovitz; A Bashiri; E Maymon; R Schreiber; D Dukler; M Katz; I Shoham-Vardi
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1998-10       Impact factor: 2.435

5.  Perinatal listeriosis--a review of twelve patients.

Authors:  H L Halliday; T Hirata
Journal:  Am J Obstet Gynecol       Date:  1979-02-15       Impact factor: 8.661

6.  Maternal and perinatal outcome of patients with preterm labor and meconium-stained amniotic fluid.

Authors:  M Mazor; B Furman; A Wiznitzer; I Shoham-Vardi; J Cohen; F Ghezzi
Journal:  Obstet Gynecol       Date:  1995-11       Impact factor: 7.661

  6 in total
  2 in total

1.  The role of the multiple banded antigen of Ureaplasma parvum in intra-amniotic infection: major virulence factor or decoy?

Authors:  Samantha J Dando; Ilias Nitsos; Suhas G Kallapur; John P Newnham; Graeme R Polglase; J Jane Pillow; Alan H Jobe; Peter Timms; Christine L Knox
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

2.  Tracheal suction at birth in non-vigorous neonates born through meconium-stained amniotic fluid.

Authors:  Sushma Nangia; Anu Thukral; Deepak Chawla
Journal:  Cochrane Database Syst Rev       Date:  2021-06-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.